News >

Potentially Transformative Treatments Emerge in Pancreatic Cancer

Caroline Seymour
Published: Wednesday, Feb 28, 2018

Allyson Ocean, MD

Allyson Ocean, MD
Antistromal agents, vitamin D analogs, high-dose intravenous (IV) vitamin C, and immunotherapy agents are just a few therapeutic strategies currently being investigated in pancreatic cancer, explains Allyson Ocean, MD.

In an interview during the meeting, Ocean, a medical oncologist and attending physician in gastrointestinal oncology at Weill Cornell Medicine/NewYork-Presbyterian Hospital, medical oncologist, The Jay Monahan Center for Gastrointestinal Health, associate professor of medicine, Weill Medical College of Cornell University, gave a glimpse of these emerging treatment strategies in pancreatic cancer.

OncLive: Please provide background of your lecture on the evolution of pancreatic cancer treatment.

Ocean: Regarding therapies, I gave background on what exists today in terms of standard of care, metastatic disease, first-line therapy, second-line therapy, sequencing regimens, and the data that led to their approvals as standard regimens.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication